181 related articles for article (PubMed ID: 21506665)
1. Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease.
Biljak VR; Pancirov D; Cepelak I; Popović-Grle S; Stjepanović G; Grubišić TŽ
Platelets; 2011; 22(6):466-70. PubMed ID: 21506665
[TBL] [Abstract][Full Text] [Related]
2. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
[TBL] [Abstract][Full Text] [Related]
3. Local inflammation occurs before systemic inflammation in patients with COPD.
He Z; Chen Y; Chen P; Wu G; Cai S
Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
[TBL] [Abstract][Full Text] [Related]
4. Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease.
Wang RT; Li JY; Cao ZG; Li Y
Respirology; 2013 Nov; 18(8):1244-8. PubMed ID: 23786593
[TBL] [Abstract][Full Text] [Related]
5. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
[TBL] [Abstract][Full Text] [Related]
6. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD.
Tkacova R; Kluchova Z; Joppa P; Petrasova D; Molcanyiova A
Respir Med; 2007 Aug; 101(8):1670-6. PubMed ID: 17449234
[TBL] [Abstract][Full Text] [Related]
7. Gamma-glutamyltransferase and C-reactive protein in stable chronic obstructive pulmonary disease.
Biljak VR; Rumora L; Cepelak I; Pancirov D; Popović-Grle S; Sorić J; Stjepanović G; Grubisić TZ
Coll Antropol; 2013 Mar; 37(1):221-7. PubMed ID: 23697277
[TBL] [Abstract][Full Text] [Related]
8. Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: the role of comorbidities.
Steiropoulos P; Papanas N; Nena E; Xanthoudaki M; Goula T; Froudarakis M; Pita E; Maltezos E; Bouros D
Angiology; 2013 Oct; 64(7):535-9. PubMed ID: 23052724
[TBL] [Abstract][Full Text] [Related]
9. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
10. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
11. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
12. Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment.
Parnham MJ; Culić O; Eraković V; Munić V; Popović-Grle S; Barisić K; Bosnar M; Brajsa K; Cepelak I; Cuzić S; Glojnarić I; Manojlović Z; Novak-Mircetić R; Oresković K; Pavicić-Beljak V; Radosević S; Sucić M
Eur J Pharmacol; 2005 Jul; 517(1-2):132-43. PubMed ID: 15964564
[TBL] [Abstract][Full Text] [Related]
13. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
[TBL] [Abstract][Full Text] [Related]
14. Relationships between platelets and inflammatory markers in rheumatoid arthritis.
Milovanovic M; Nilsson E; Järemo P
Clin Chim Acta; 2004 May; 343(1-2):237-40. PubMed ID: 15115702
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation.
Stanojkovic I; Kotur-Stevuljevic J; Milenkovic B; Spasic S; Vujic T; Stefanovic A; Llic A; Ivanisevic J
Respir Med; 2011 Oct; 105 Suppl 1():S31-7. PubMed ID: 22015083
[TBL] [Abstract][Full Text] [Related]
17. Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease.
Malerba M; Olivini A; Radaeli A; Ricciardolo FL; Clini E
Curr Med Res Opin; 2016 May; 32(5):885-91. PubMed ID: 26824631
[TBL] [Abstract][Full Text] [Related]
18. Relationship between bone resorption, oxidative stress and inflammation in severe COPD exacerbation.
Stanojkovic I; Kotur-Stevuljevic J; Spasic S; Milenkovic B; Vujic T; Stefanovic A; Ivanisevic J
Clin Biochem; 2013 Nov; 46(16-17):1678-82. PubMed ID: 23954853
[TBL] [Abstract][Full Text] [Related]
19. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity.
Yazici S; Yazici M; Erer B; Erer B; Calik Y; Ozhan H; Ataoglu S
Platelets; 2010; 21(2):122-5. PubMed ID: 20050760
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation and inflammatory response in patients with non-dipper hypertension.
Kaya MG; Yarlioglues M; Gunebakmaz O; Gunturk E; Inanc T; Dogan A; Kalay N; Topsakal R
Atherosclerosis; 2010 Mar; 209(1):278-82. PubMed ID: 19782364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
